Home » Topics » Conferences

Conferences
RSS

NCI evaluates stability of SarCNU

Sep. 16, 1997

New compounds for influenza targeting cap-dependent endonuclease

Sep. 16, 1997

Merck Frosst reports further data on COX-2 inhibitor L-768277

Sep. 16, 1997

Potent and selective COX-2 inhibitors synthesized at Boehringer Ingelheim

Sep. 16, 1997

Glaxo Wellcome develops new influenza sialidase inhibitors

Sep. 16, 1997

Mitsubishi describes synthesis and activity of MKC-242

Sep. 15, 1997

Novel neuroprotective agent developed at Takeda

Sep. 15, 1997

Novartis evaluates SDZ-267-489 and analogues for increasing HDL cholesterol

Sep. 15, 1997

Novel antibacterial agents from R.W. Johnson

Sep. 15, 1997

Potent GH secretagogues synthesized at Merck & Co.

Sep. 15, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...